Preparation of lipopolysaccharide derived from Pantoea agglomerans labeled with fluorescence as a tracer for kinetics analysis

Anticancer Research

Volumn 30, Issue 8, 2010, Pages 3151-3157

  Kadowaki, Takeshi ^a   Inagawa, Hiroyuki ^b,c,d   Kohchi, Chie ^a,c,d,e   Hirashima, Mitsuomi ^a   Soma, Gen Ichiro ^a,c,d,e  

^a KAGAWA UNIVERSITY   (Japan)

^b NATIONAL FISHERIES UNIVERSITY   (Japan)

^c Research and Development Department Macrophi Inc   (Japan)

^d TOKYO UNIVERSITY OF SCIENCE   (Japan)

^e TOKUSHIMA BUNRI UNIVERSITY   (Japan)

Author keywords

FITC LPS; Fluorescence label; IP PA1; LPS

Indexed keywords

ANTIALLERGIC AGENT; ANTINEOPLASTIC AGENT; BACTERIUM LIPOPOLYSACCHARIDE; FLUORESCEIN ISOTHIOCYANATE; NITRIC OXIDE; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE IP PA1, PANTOEA AGGLOMERANS; LIPOPOLYSACCHARIDE IP-PA1, PANTOEA AGGLOMERANS;

ARTICLE; CONCENTRATION RESPONSE; DRUG ACTIVITY; DRUG BINDING; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG METABOLISM; FLOW CYTOMETRY; FLUORESCENCE; GEL FILTRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PANTOEA AGGLOMERANS; PRIORITY JOURNAL; THIN LAYER CHROMATOGRAPHY; ANIMAL; CELL LINE; GEL CHROMATOGRAPHY; KINETICS; METABOLISM; MOUSE;

ANIMALS; CELL LINE; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, THIN LAYER; FLOW CYTOMETRY; FLUORESCENCE; KINETICS; LIPOPOLYSACCHARIDES; MICE;

EID: 77957350277     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Bone RC: Sepsis syndrome. New insights into its pathogenesis and treatment. Infect Dis Clin North Am 5: 793-805, 1991.
2. Raetz CR: Biochemistry of endotoxins. Annu Rev Biochem 59: 129-170, 1990.
3. Inagawa H, Nishizawa T, Noguchi K, Minamimura M, Takagi K, Goto S, Soma GI and Mizuno D: Anti-tumor effect of lipopolysaccharide by intradermal administration as a novel drug delivery system. Anticancer Res 17: 2153-2158, 1997.
4. Inagawa H, Nishizawa T, Takagi K, Goto S, Soma GI and Mizuno D: Antitumor mechanism of intradermal administration of lipopolysaccharide. Anticancer Res 17: 1961-1964, 1997.
5. Kohchi, C, Inagawa H, Nishizawa T, Yamaguchi T, Nagai S and Soma GI: Applications of lipopolysaccharide derived from Pantoea agglomerans (IP-PA1) for health care based on macrophage network theory. J Biosci Bioeng 102: 485-496, 2006. (Pubitemid 46162274)
6. Kadowaki T, Yasui Y, Takahashi Y, Kohchi C, Soma GI and Inagawa H: Comparative immunological analysis of innate immunity activation after oral administration of wheat fermented extract to teleost fish. Anticancer Res 29: 4871-4877, 2009.
7. Hurley JC: Concordance of endotoxemia with Gram-negative bacteremia in patients with Gram-negative sepsis: a meta-analysis. J Clin Microbiol 32: 2120-2127, 1994.
8. Hurley JC: Reappraisal with meta-analysis of bacteremia, endotoxemia, and mortality in Gram-negative sepsis. J Clin Microbiol 33: 1278-1282, 1994.
9. Novitsky TJ, Roslansky PF, Siber GR and Warren HS: Turbidimetric method for quantifying serum inhibition of Limulus amoebocyte lysate. J Clin Microbiol 21: 211-216, 1985.
10. Novitsky TJ and Roslansky PF: Quantification of endotoxin inhibition in serum and plasma using a turbidimetric LAL assay. Prog Clin Biol Res 189: 181-196, 1985.
11. Haeffner-Cavaillon, N, Chaby R, Cavaillon JM and Szabo L: Lipopolysaccharide receptor on rabbit peritoneal macrophages. I. Binding characteristics. J Immunol 128: 1950-1954, 1982.
12. Warner SJ, Savage N and Mitchell D: Characteristics of lipopolysaccharide interaction with human peripheral-blood monocytes. Biochem J 232: 379-383, 1985. (Pubitemid 16210768)
13. Blondin, C, Le Dur A, Cholley B, Caroff M and Haeffner-Cavaillon N: Lipopolysaccharide complexed with soluble CD14 binds to normal human monocytes. Eur J Immunol 27: 3303-3309, 1997.
14. Troelstra A, Antal-Szalmas P, de Graaf-Miltenburg LA, Weersink AJ, Verhoef J, Van Kessel KP and Van Strijp JA: Saturable CD14-dependent binding of fluorescein-labeled lipopolysaccharide to human monocytes. Infect Immun 65: 2272-2277, 1997.
15. Triantafilou M, Triantafilou K and Fernandez N: Rough and smooth forms of fluorescein-labelled bacterial endotoxin exhibit CD14/LBP dependent and independent binding that is influenced by endotoxin concentration. Eur J Biochem 267: 2218-2226, 2000.
16. Weersink AJ, Van Kessel KP, Torensma R, Van Strijp JA and Verhoef J: Binding of rough lipopolysaccharides (LPS) to human leukocytes. Inhibition by anti-LPS monoclonal antibody. J Immunol 145: 318-324, 1990. (Pubitemid 20217418)
17. Hornef MW, Normark BH, Vandewalle A and Normark S: Intracellular recognition of lipopolysaccharide by toll-like receptor 4 in intestinal epithelial cells. J Exp Med 198: 1225-1235, 2003.
18. Thieblemont N and Wright SD: Transport of bacterial lipopolysaccharide to the golgi apparatus. J Exp Med 190:523-534, 1999.
19. Triantafilou, K, Triantafilou M and Fernandez N: Lipopolysaccharide (LPS) labeled with Alexa 488 hydrazide as a novel probe for LPS binding studies. Cytometry 41: 316-320, 2000.
20. Schroeder TH, Lee MM, Yacono PW, Cannon CL, Gerceker AA, Golan DE and Pier GB: CFTR is a pattern recognition molecule that extracts Pseudomonas aeruginosa LPS from the outer membrane into epithelial cells and activates NF-kappa B translocation. Proc Natl Acad Sci USA 99: 6907-6912, 2002.
21. Hua, KF, Hsu HY, Chao LK, Chen ST, Yang WB, Hsu J and Wong CH: Ganoderma lucidum polysaccharides enhance CD14 endocytosis of LPS and promote TLR4 signal transduction of cytokine expression. J Cell Physiol 212: 537-550, 2007. (Pubitemid 47025644)
22. Granger DL, Taintor RR, Boockvar KS and Hibbs Jr JB: Measurement of nitrate and nitrite in biological samples using nitrate reductase and Griess reaction. Methods Enzymol 268: 142-151, 1996.
23. Ding AH, Nathan CF and Stuehr DJ: Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol 141: 2407-2412, 1988.
24. Proctor RA and Textor JA: Activation and inhibition of Limulus amebocyte lysate coagulation by chemically defined substructures of lipid A. Infect Immun 49: 286-290, 1985.
25. Takayama K, Qureshi N, Raetz CR, Ribi E, Peterson J, Cantrell JL, Pearson FC, Wiggins J and Johnson AG: Influence of fine structure of lipid A on Limulus amebocyte lysate clotting and toxic activities. Infect Immun 45: 350-355, 1984.
26. Akira S: Toll-like receptors: lessons from knockout mice. Biochem Soc Trans 28: 551-556, 2000.
27. Teruya, T, Tatemoto H, Konishi T and Tako M: Structural characteristics and in vitro macrophage activation of acetyl fucoidan from Cladosiphon okamuranus. Glycoconj J 26: 1019-1028, 2009.
28. Dinarello CA: Interleukin-1 and interleukin-1 antagonism. Blood 77: 1627-1652, 1991.
29. Beutler B and Cerami A: Tumor necrosis, cachexia, shock, and inflammation: a common mediator. Annu Rev Biochem 57: 505-518, 1988.
30. Park BS, Song DH, Kim HM, Choi BS, Lee H and Lee JO: The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 458: 1191-1195, 2009.
31. Bergstrand A, Svanberg C, Langton M and Nyden M: Aggregation behavior and size of lipopolysaccharide from Escherichia coli O55:B5. Colloids Surf B Biointerfaces 53: 9-14, 2006.
32. Santos NC, Silva AC, Castanho MA, Martins-Silva J and Saldanha C: Evaluation of lipopolysaccharide aggregation by light scattering spectroscopy. Chembiochem 4: 96-100, 2003. (Pubitemid 36114216)
33. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K and Akira S: Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the LPS gene product. J Immunol 162: 3749-3752, 1999.
34. Qureshi ST, Lariviere L, Leveque G, Clermont S, Moore KJ, Gros P and Malo D: Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J Exp Med 189: 615-625, 1999.
35. Andreakos E, Sacre SM, Smith C, Lundberg A, Kiriakidis S, Stonehouse T, Monaco C, Feldmann M and Foxwell BM: Distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP. Blood 103: 2229-2237, 2004.
36. Rosenberger CM and Finlay BB: Phagocyte sabotage: disruption of macrophage signaling by bacterial pathogens. Nat Rev Mol Cell Biol 4: 385-396, 2003.
37. Raetz CR, Reynolds CM, Trent MS and Bishop RE: Lipid A modification systems in Gram-negative bacteria. Annu Rev Biochem 76: 295-329, 2007.
38. Elomaa O, Kangas M, Sahlberg C, Tuukkanen J, Sormunen R, Liakka A, Thesleff L, Kraal G and Tryggvason K: Cloning of a novel bacteria-binding receptor structurally related to scavenger receptors and expressed in a subset of macrophages. Cell 80: 603-609, 1995.
39. Pearson AM: Scavenger receptors in innate immunity. Curr Opin Immunol 8: 20-28, 1996.
40. Janeway CA Jr. and Medzhitov R: Innate immune recognition. Annu Rev Immunol 20: 197-216, 2002.
41. Le Cabec V, Carreno S, Moisand A, Bordier C and Maridonneau-Parini I: Complement receptor 3 (CD11b/CD18) mediates type I and type II phagocytosis during nonopsonic and opsonic phagocytosis, respectively. J Immunol 169: 2003-2009, 2002.
42. Gegner, JA, Ulevitch RJ and Tobias PS: Lipopolysaccharide (LPS) signal transduction and clearance. Dual roles for LPS binding protein and membrane CD14. J Biol Chem 270: 5320-5325, 1995.
43. Hampton RY, Golenbock DT, Penman M, Krieger M and Raetz CR: Recognition and plasma clearance of endotoxin by scavenger receptors. Nature 352: 342-344, 1991. (Pubitemid 21912355)
44. Grunwald U, Fan X, Jack RS, Workalemahu G, Kallies A, Stelter F and Schutt C: Monocytes can phagocytose Gram-negative bacteria by a CD14-dependent mechanism. JImmunol 157: 4119-4125, 1996.
45. Munford RS and Hall CL: Detoxification of bacterial lipopolysaccharides (endotoxins) by a human neutrophil enzyme. Science 234: 203-205, 1986.
46. Kitchens RL, Ulevitch RJ and Munford RS: Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway. J Exp Med 176: 485-494, 1992.
47. Tsukioka D, Nishizawa T, Miyase T, Achiwa K, Suda T, Soma GI, and Mizuno D: Structural characterization of lipid A obtained from Pantoea agglomerans lipopolysaccharide. FEMS Microbiol Lett 149: 239-244, 1997. (Pubitemid 27163351)